Peter DiRoma
General Counsel at RA PHARMACEUTICALS, INC.
Network origin in Peter DiRoma first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 23 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Peter DiRoma via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| UCB | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer General Counsel | |
| INOZYME PHARMA, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member | |
Cerevance, Inc.
 Cerevance, Inc. Medical SpecialtiesHealth Technology Cerevance, Inc. provides pharmaceutical services. The firm discovers new treatments for central nervous system diseases. Its platform enables to profile specific brain cell types including both neurons and glial cells in mature human brain tissue. The company was founded by Bradley A. Margus and Mark Carlton in 2016 and is headquartered in Boston, MA. | Medical Specialties | Director/Board Member Director/Board Member | |
| TETRAPHASE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
AstraZeneca LP
 AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Pharmaceuticals: Major | Corporate Officer/Principal Private Equity Investor | |
| SYNLOGIC, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
RA Capital Management LP (Private Equity)
 RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA. | Investment Managers | Private Equity Investor Private Equity Investor | |
| BLACK DIAMOND THERAPEUTICS, INC. | Biotechnology | Director/Board Member Investor Relations Contact | |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Director/Board Member Director of Finance/CFO | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Graduate Degree Undergraduate Degree | |
| RHYTHM PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Consultant / Advisor Consultant / Advisor | |
| SOLID BIOSCIENCES INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
Synlogic Operating Co., Inc.
 Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Lumos Pharma Sub, Inc.
 Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Lumos Pharma Sub, Inc. develops and commercializes a novel treatment for the rare disease creatine transporter deficiency. It focuses on bringing novel therapies to patients afflicted with unmet medical needs in severe, rare, and genetic diseases. The firm's technology LUM-001 is a repurposed small molecule that is a kinetically similar analog of creatine and has shown promising therapeutic potential for the treatment of creatine transporter deficiency. Lumos Pharma was founded by Richard J. Hawkins in 2010 and is headquartered in Austin, TX. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
| University of Delaware | College/University | Undergraduate Degree Undergraduate Degree | |
| VOR BIOPHARMA INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Chief Executive Officer | |
SetPoint Medical Corp.
 SetPoint Medical Corp. Medical/Nursing ServicesHealth Services SetPoint Medical Corp. operates as a biomedical technology company, which engages in the development of therapies for patients with inflammatory autoimmune diseases such as rheumatoid arthritis and Crohn?s disease. The company was founded by Kevin J. Tracey, Shaw H. Warren, and James W. Broderick in 2006 and is headquartered in Santa Clarita, CA. | Medical/Nursing Services | Chief Operating Officer | |
UCB Celltech
 UCB Celltech BiotechnologyHealth Technology Part of UCB SA, UCB Celltech is a British company that develops novel therapeutic products for humans. The company is based in Slough, UK and was founded in 2006. | Biotechnology | Director/Board Member | |
| AKEBIA THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Maine | College/University | Undergraduate Degree | |
| University of Massachusetts | College/University | Graduate Degree | |
| Babson College | College/University | Masters Business Admin | |
| University of Florida | College/University | Doctorate Degree | |
| University of Cambridge | College/University | Graduate Degree | |
| GILEAD SCIENCES, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| University College London | College/University | Doctorate Degree | |
Pepgen Ltd.
 Pepgen Ltd. Packaged SoftwareTechnology Services Pepgen Ltd. engages in research and experimental development on biotechnology. The company was founded on January 25, 2018 and is headquartered in Oxford, the United Kingdom. | Packaged Software | Chairman | |
| PEPGEN INC. | Biotechnology | Chairman | |
| University of Cape Town | College/University | Undergraduate Degree | |
Bausch & Lomb, Inc.
 Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | Medical Specialties | Corporate Officer/Principal | |
Civitas Therapeutics, Inc.
 Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY. | Biotechnology | Director/Board Member | |
KalVista Pharmaceuticals Ltd.
 KalVista Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology KalVista Pharmaceuticals Ltd. develops novel plasma kallikrein inhibitors. It also engages in the development of serine protease inhibitors and novel plasma kallikrein inhibitors represent a, approach to the treatment of DME, a leading cause of adult visual loss, plasma kallikrein inhibitors target a distinct molecular pathway and as such have the potential to offer those patients an effective treatment option. The firm has a clinical and advanced pre-clinical product pipeline targeting both intravitreal injection and oral administration, and its plasma kallikrein inhibitors can be applied to additional indications in ophthalmology. The company was founded by Lloyd Paul Aiello, Andrew Crockett, Robert Haigh and Edward P. Feener in 2011 and is headquartered in Porton Down, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| KALA BIO, INC. | Pharmaceuticals: Major | Director/Board Member | |
| KALVISTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| EIDOS THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| SATSUMA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
TARIS BioMedical LLC
 TARIS BioMedical LLC Pharmaceuticals: MajorHealth Technology TARIS BioMedical LLC operates as a clinical-stage pharmaceutical company. It specializes in urology, continuous local dosing, bladder diseases, oncology, voiding dysfunction. The company was founded by Robert S. Langer Jr., Christine Bunt, and Michael J. Cima in 2008 and is headquartered in Lexington, MA. | Pharmaceuticals: Major | Director/Board Member | |
| Big Brothers Big Sisters of Massachusetts Bay | Corporate Officer/Principal | ||
| Texas Radiological Society | Director/Board Member | ||
| Loyola University Maryland, Inc. | College/University | Graduate Degree | |
Integrated Health Services, Inc.
 Integrated Health Services, Inc. Hospital/Nursing ManagementHealth Services Integrated Health Services, Inc. provides post-acute healthcare services. Its Post-acute care is the provision of a continuum of care to patients following discharge from an acute care hospital. Its post-acute care services and products include inpatient services, home respiratory care & durable medical equipment, diagnostic services and lithotripsy which is a non-invasive technique that uses shockwaves to disintegrate kidney stones primarily on an outpatient basis. The company's post-acute care network is designed to address the cost containment measures implemented by private insurers & managed care organizations and limitations on government reimbursement of hospital costs that have resulted in the discharge from hospitals of many patients who continue to require medical and rehabilitative care. | Hospital/Nursing Management | Corporate Officer/Principal |
Statistics
International
| United States | 41 |
| United Kingdom | 6 |
| Belgium | 3 |
| Denmark | 2 |
| South Africa | 2 |
Sectoral
| Health Technology | 30 |
| Consumer Services | 11 |
| Finance | 4 |
| Health Services | 4 |
| Commercial Services | 2 |
Operational
| Director/Board Member | 122 |
| Independent Dir/Board Member | 50 |
| Corporate Officer/Principal | 39 |
| Undergraduate Degree | 17 |
| Chief Tech/Sci/R&D Officer | 14 |
Most connected contacts
| Insiders | |
|---|---|
| Ed Mathers Mathers | 47 |
| Peter Bisgaard | 28 |
| David Lubner | 19 |
| Robert A. Heft | 18 |
| Raj Shah | 16 |
| Timothy Pearson | 15 |
| Charl van Zyl | 12 |
| Simon Read | 12 |
| Dhavalkumar Patel | 12 |
| Doug Treco Treco | 11 |
| Denelle Waynick | 11 |
| Aoife Brennan | 10 |
| Ramin Farzaneh-Far | 9 |
| Alexander Cumbo | 8 |
| Kerry Black | 6 |
- Stock Market
- Insiders
- Peter DiRoma
- Company connections
